Kaplan Fox & Kilsheimer LLP is Investigating Securities Fraud Claims Against Mobileye Global Inc.
Kaplan Fox & Kilsheimer LLP
MBLY Investor Alert: Kaplan Fox & Kilsheimer LLP is Investigating Securities Fraud Claims Against Mobileye Global Inc. NEW YORK, NY - (NewMediaWire) - January 12, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Mobileye Global Inc. (“Mobileye” or the “Company”) (NASDAQ: MBLY). Click Here to Join Investigation. If you acquired Mobileye securities and would like to discuss our investigation, please click here or contact us by emailing pmayer@kaplanfox.com or by calling (646) 315-9003. On January 4, 2024, before the market opened, Mobileye issued a press release entitled "Mobileye Releases Preliminary FY2023 Financial Results and Initial 2024 Outlook" which, among other things, states that Mobileye “[has] become aware of excess inventory at our customers, which we believe to be 6-7 million units of EyeQ® SoCs” and that "[w]e currently expect Q1 revenue to be down approximately 50%, as compared to the $458 million revenue generated in the first quarter of 2023." Following this news, the price of Mobileye stock fell $9.75 per share, more than 24%, to close at $29.97 per share on January 4, 2024. WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. If you have any questions about this investigation, please contact: Pamela A. Mayer Laurence D. King
Dissemination of a CORPORATE NEWS, transmitted by EQS Group. |
1814579 15-Jan-2024